Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Indian drugmaker Dr Reddy's Laboratories has received the final FDA approval for nabumetone tablets, according to Reuters.
Subscribe to our email newsletter
Nabumetone is a non-steroidal anti-inflammatory drug used to treat arthritis-related pain.
Dr Reddy’s Laboratories is a pharmaceutical company that produces active pharmaceutical ingredients and intermediates, and finished dosage forms and biologics products, and markets them globally, with a focus on India, the US, Europe and Russia.